Skip to main content
. 2009 Feb 18;2:179–188. doi: 10.2147/ott.s3863

Table 3.

Adverse events in patients >65 years old in the nab-paclitaxel group compared with the CrEL-paclitaxel group

Adverse events Nab-paclitaxel
CrEL paclitaxel
% of pts % of pts
Neutropenia 23 59
Leukopenia 10 31
Nausea 20 38
Hyperglycemya 0 19
Flushing 0 16